The human data for addiction is observational and the mechanistic data is looking at rodents
This oncologic safety concern is magnified by the fact that many cancers remain clinically silent during their early developmental stages
[DOI] [PMC free article] [PubMed] [Google Scholar] Arslanian SA, Hannon T, Zeitler P, Chao LC, Boucher-Berry C, Barrientos-Prez M, Bismuth E, Dib S, Cho JI, Cox D
Curiously, this isn't the only way Ozempic and other GLP-1 drugs can affect bone density
The new treatment a once-weekly injectable from Novo Nordisk, a Danish pharmaceutical company that has hired many leading diabetes and obesity scientists as consultants is poised to safely help many people with health-threatening obesity, physicians and researchers say
GLP-1 medications mimic this hormones effects in the body, improving insulin production, slowing down food digestion, and reducing appetite